Shmuely et al. reported that H. pylori CagA+ seropositivity is enhanced in gastric and colon cancers [18], while Fireman et al. demonstrated a correlation between H. pylori seropositivity and CA19-9 elevation in patients with CC [19]. Here, S100A8 is linked to colonic neoplasm.